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1. Introduction 
Chlamydia infections are associated with a wide range of diseases. C. trachomatis (serovars A, 
B, Ba and C) causes trachoma, the world’s leading cause of infectious blindness. Serovars D 
through K are most commonly associated with sexually transmitted diseases and can cause 
infertility in women if left untreated [Paavonen and Eggert-Kruse, 1999]. Sexually 
transmitted diseases (STDs) are prevalent in every society in the world, including in 
developed countries (United States Centers for Disease Control [CDC]). Therefore, they 
represent a serious public health concern. Public programs aimed at increasing people’s 
awareness of the risks these pathogens pose have helped in controlling the spread of 
disease. Nevertheless, Chlamydia is still the most frequently reported STD in the United 
States. In 2009, 1.2 million new cases of Chlamydia infections were reported in the United 
States alone, but the actual number of infections is estimated to be higher due to a large 
number of unreported cases (CDC). Vaccination is the gold standard for disease prevention, 
but despite years of research, no vaccines exist for bacterial STDs. The typical course of 
treatment for Chlamydia infections involves the use of antibiotics, but there is emerging 
evidence that non-specific antibacterial agents can cause lasting damage to an individual by 
adversely affecting the homeostasis of the microbiota, which is the collection of bacteria that 
positively affect normal human functioning [Stewardson et al., 2011].  
The Chlamydia life cycle consists of two distinct stages: the elementary body (EB) and the 
reticulate body (RB) stages. They are characterized by differences in morphology, 
metabolism, and infectivity [Tamura et al., 1971]. Elementary bodies are metabolically 
inactive but infectious (Figure 1-right). Extensive disulphide cross-linking of cysteine-rich 
outer membrane proteins allows the EBs to survive outside the host cell [Hackstadt et al., 
1985]. Upon coming in contact with a host cell, the EB is endocytosed into a plasma 
membrane-derived phagosome in which it eventually differentiates into a larger, 
metabolically active (but non-infectious) organism called a reticulate body. The RB remodels 
the phagosome in a multi-step process that is still incompletely understood (see Figure 1-
right). This remodeled phagosome is called an inclusion and is distinguished by the presence 
of bacterial virulence-associated proteins (also known as effectors) on its surface in addition 
to host proteins that are not normally found on typical phagosomes. The remodeling 
process involves the action of a Type 3 Secretion System (T3SS) [Stephens et al., 1998]. 
Pharmacological inhibition of T3SS proteins halts the translocation of certain bacterial 
proteins into the inclusion membrane [Muschiol et al., 2006].  
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Chlamydia express bacterial effectors on the inclusion, including proteins of largely 
uncharacterized function called inclusion proteins, or Incs [Li et al., 2008; Rockey et al., 1995; 
Scidmore and Hackstadt, 2001]. Inc family members are found across species of Chlamydiae 
but do not share a high level of sequence homology. They do, however, share several 
structural features including a characteristic bi-lobed N-terminal transmembrane domain 
[Bannantine et al., 2000] and a cytosolic C-terminal domain capable of interacting with host 
proteins [Rockey et al., 1997]. These interactions are discussed in further detail below. Inc 
proteins likely play a major role in bacterial pathogenesis. However, their exact roles in 
infection remain unclear, largely due to the lack of genetic techniques to easily and rapidly 
generate targeted knockouts of these genes. 
 
Fig. 1. Comparison of Typical Phagosomal Maturation and Maturation of Chlamydia 
Phagosomes (Inclusions). (Left) A typical phagosome fuses with early and late endocytic 
compartments and gradually acidifies. Upon fusion with the lysosome, it becomes a 
phagolysosome and the bacteria inside are destroyed. (Right) Chlamydia elementary bodies 
are internalized into separate phagosomes. In the case of C. trachomatis, these phagosomes 
eventually fuse with each other into a large inclusion. Inside the cell, the Chlamydia inclusion 
interacts with early and late endocytic compartments, but avoids fusing with lysosomes. In 
addition, it promotes fusion with Golgi-derived vesicles, lipid droplets (LD), and multi-
vesicular bodies (MVB) to acquire host nutrients. The Chlamydia inclusions do not greatly 
acidify as in typical phagosomes. 
Chlamydiae possess a highly condensed genome consisting of just over 1 million bases. This 
genome lacks many genes and gene networks essential for metabolism [Stephens et al., 
1998]. As a result, Chlamydiae are obligate intracellular bacteria and must adapt to thrive 
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under extremely challenging conditions inside host cells. In particular, the pathogen has to 
co-opt host resources such as nutrients, proteins, or lipids for its own use without triggering 
immune defenses or killing the host. To this end, Chlamydiae have evolved sophisticated 
mechanisms to support their intracellular lifestyle. For example, Chlamydia inclusions 
appear to fuse with a select set of host vesicles while avoiding fusion with other 
organelles—namely lysosomes (Figure 1- Right) [Fields and Hackstadt, 2002]. Fusion with 
the host vesicles likely results in the delivery of vital bioactive compounds that the bacteria 
then use to support its growth and survival inside the cell. However, the metabolic 
pathways involved in the utilization of host compounds are incompletely understood. 
Inclusions do not maturate to phagolysosomes (Figure 1-Right), that is to say they do not 
display markers specific to lysosomes [reviewed in [Fields and Hackstadt, 2002]], in contrast 
to many non-pathogenic bacteria (Figure 1-Left). By inhibiting interactions with the 
endocytic pathway, Chlamydiae are able to evade destruction by innate immune defenses. 
How the bacteria accomplish this task is the subject of intense research. 
Chlamydia infection is a complex process involving many factors. In this chapter, we will 
review data that suggest that Chlamydia inclusions selectively promote fusion with Golgi-
derived vesicles, lipid droplets, and multivesicular bodies while avoiding fusion with the 
lysosomal compartments. We will look at how Chlamydia spp. remodel their inclusion using 
a Type 3 Secretion System and discuss new research that aims at understanding host vesicle 
re-trafficking at the molecular level. 
2. The Chlamydia inclusion is a remodeled version of the phagosome 
In healthy individuals, innate immune cells can recognize and destroy invading bacteria 
using phagocytosis [Metchnikoff, 1891]. Bacteria are rapidly internalized into a special 
organelle called a phagosome that successively fuses with early and late endosomes resulting 
in acidification of the phagosome. During the final step of maturation, the acidified 
phagosome fuses with lysosomes to become a phagolysosome (Figure 1-Left) [Botelho and 
Grinstein, 2011]. Inside the phagolysosome, bacteria are destroyed through the action of 
proteases, hydrolytic enzymes and toxic compounds such as reactive oxygen species 
[Botelho and Grinstein, 2011]. Chlamydiae however, avoid this degradative pathway 
altogether (Figure 1-Right). At no point during infection are lysosomal markers found on 
the inclusion membrane [Fields and Hackstadt, 2002]. This observation suggests that 
Chlamydia modify the inclusion membrane to render it undetectable to lysosomes thus 
allowing it to avoid fusion with those compartments and eventual acidification.  
2.1 Chlamydia modify the phosphatidylserine content of the inclusion they inhabit  
One way to remodel the phagosomal membrane is by manipulating its lipid composition. A 
recent report looked at the localization of phosphatidylserine (PS) on phagosomes of inert 
and biologically active materials [Yeung et al., 2009]. Using a novel protein probe (referred 
to as Lact-C2) for membrane charge and lipid composition, the authors determined that PS 
contributes significantly to the lipid content of phagosomes. During Chlamydia infection 
however, Lact-C2 was found on the inclusion of C. trachomatis at only 6 hours post infection 
(hpi). At 18hpi, there was little or no Lact-C2 detected on the inclusion suggesting that C. 
trachomatis reorganized the lipid content of its inclusion. At this point, it is impossible to 
conclude with certainty what mechanisms are employed by the bacteria to alter the cellular 
distribution of PS.  
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In addition to remodeling the lipid composition of phagosomes, intracellular bacteria such 
as Chlamydia also modify the proteins on the membrane surface. It has been established that 
Chlamydia employs a Type 3 Secretion System to deliver bacterial proteins into the inclusion 
membrane and the host cytosol [Hueck, 1998; Subtil et al., 2001].  
2.2 Secretion of Chlamydia proteins by a type 3 secretion system is necessary to 
protect the inclusion 
Type 3 Secretion Systems (T3SS) are multimeric bacterial needle-like superstructures found 
in many Gram-negative pathogenic bacteria. T3SS allow for the transport of effectors 
through the bacterial membranes and across a eukaryotic membrane [Worrall et al., 2011]. 
The genome sequence of C. trachomatis reveals three distinct gene clusters containing open 
reading frames (ORFs) encoding putative gene products that show significant homology to 
known T3SS proteins from Yersinia spp. These genes include the pore-forming complex 
YscC, the structural components of the inner membrane complex YscJ, YscR, YscS, YscT, and 
YscU, and the ATPase YscN and its binding partner YscL [Stephens et al., 1998] (Figure 2A). 
The Chlamydia protein CopB is found on the inclusion membrane and is believed to be a 
translocator operating as the gateway for effectors to enter the host [Peters et al., 2007]. 
 
Fig. 2. Chlamydia Type 3 Secretion System. (A) The Type 3 Secretion System (T3SS) shuttles 
proteins from the bacterial cytoplasm into the host cytosol or inclusion membrane. Shown 
here is a schematic depicting the transport of an inclusion protein from the bacterial 
cytoplasm where it is bound to a chaperone protein, to the inclusion membrane through the 
T3SS. OM = outer membrane (bacteria); IM = inner membrane (bacteria). (B) Schematic 
representation of a typical inclusion protein (Inc). The N-terminal peptide faces the cytosol. 
The bi-lobed transmembrane domain inserts twice into the bilayer, allowing the C-terminal 
peptide to face the cytosol as well.  
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Secretion systems are mostly known for their ability to inject soluble effectors into the host 
cytosol, however they are also capable of shuttling proteins containing hydrophobic 
transmembrane domains (Figure 2). The inability to genetically insert recombinant fusion 
proteins into Chlamydia has necessitated the use of heterologous systems to study proteins 
secreted by a Chlamydia T3SS. Dautry-Varsat and co-workers demonstrated that the 
inclusion membrane proteins IncA, IncB, IncC, along with Cpn0026, Cpn0146, Cpn0308, 
Cpn0367, and Cpn0585 from C. pneumoniae are transported through a T3SS in Shigella flexneri 
[Subtil et al., 2001]. The N-terminal domains of these proteins were fused to a cya (adenylate 
cyclase) reporter gene and secretion was measured by western blotting supernatant and 
pellet fractions. These experiments demonstrated that the secretion signal was encoded in 
the N-terminal region of the Chlamydia protein. Interestingly, all of the proteins mentioned 
above with the exception of IncB and IncC contain N-terminal bi-lobed transmembrane 
domains. This led to the speculation that the secretion signal may be located in that region 
(Figure 2B). Follow-up studies using the same heterologous system identified fifteen C. 
trachomatis proteins shown to localize to the inclusion membrane (as measured by 
immunofluoresence microscopy) and to be secreted by the S. flexneri T3SS [Dehoux et al., 
2011].  
The sequencing of the C. trachomatis genome [Stephens et al., 1998] allowed Chlamydia 
research to enter the bioinformatics age. One of the first efforts to predict inclusion 
membrane proteins (Inc) used the bi-lobed transmembrane domain architecture as a 
criterion for localization to the inclusion [Bannantine et al., 2000]. This was based on the 
observation that IncA, IncB, and IncC each contained this unusual motif and were identified 
as being on the inclusion membrane. The authors of this study found forty-six ORFs in the 
C. trachomatis genome encoding for proteins predicted to possess a bi-lobed transmembrane 
domain, seventy ORFs were found in the genome of C. pneumonia, and twenty-three ORFs 
were found in both organisms. To confirm localization to the inclusion membrane, 
immunofluorescence was employed using antibodies directed against six of the identified 
putative proteins including CT484, CT223, CT229, CT233, CT442, and CT288 (Table 1). Only 
CT484 was undetectable by this method.  
 
Inc Protein Reference Inc Protein Reference 
IncA 
IncC 
IncD 
IncE 
IncG 
CT223 
CT226 
CT228 
CT229 
CT249 
[Subtil et al., 2005] 
[Subtil et al., 2005] 
[Subtil et al., 2005] 
[Subtil et al., 2005] 
[Subtil et al., 2005] 
[Subtil et al., 2005] 
[Dehoux et al., 2011] 
[Dehoux et al., 2011] 
[Subtil et al., 2005] 
[Dehoux et al., 2011] 
CT288 
CT358 
CT440 
CT442 
CT850 
Cpn0146 
Cpn0186 
Cpn0308 
Cpn0585 
Cpn1027 
[Subtil et al., 2005] 
[Dehoux et al., 2011] 
[Dehoux et al., 2011] 
[Subtil et al., 2005] 
[Dehoux et al., 2011] 
[Dehoux et al., 2011] 
[Subtil et al., 2001] 
[Subtil et al., 2001] 
[Subtil et al., 2001] 
[Dehoux et al., 2011] 
Table 1. Chlamydia Inc Proteins Secreted by a Type 3 Secretion System. List of putative 
inclusion-bound bacterial proteins that are translocated through a Type 3 Secretion System. 
Proteins beginning with “CT” are from C. trachomatis and proteins beginning with “Cpn” 
are from C. pneumoniae. IncA,C,D,E, and G are from C. trachomatis. 
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This concept was extended when Zhong and colleagues investigated the intracellular 
location of fifty putative C. trachomatis inclusion membrane proteins [Li et al., 2008]. 
Antibodies were raised to putative Incs fused to either red fluorescent protein (RFP) or 
glutathione-S-transferase (GST). These antibodies were later used to confirm localization to 
the inclusion membrane. In total, twenty-two proteins were visible on the inclusion, seven 
were located within the inclusion, and twenty-one were undetectable by 
immunofluorescence.  
Further evidence for a T3SS in Chlamydia has come in the form of pharmacologic inhibition 
of putative secretion-associated proteins. The compound INP0400, an inhibitor of the T3SS 
in Y. pseudotuberculosis, was shown to inhibit Chlamydia growth in cell lines when 
administered early during infection. For example, there was a decrease of the accumulation 
of 14-3-3, a host phosphoserine-binding protein, around the inclusion, indicative of little or 
no IncG reaching the inclusion membrane [Muschiol et al., 2006]. The 14-3-3 family of 
proteins includes numerous members implicated in a myriad of pathways including 
apoptosis and tumor suppression [Morrison, 2009]. When INP0400 was added to cell culture 
media during the mid-cycle phase of infection, IncA function was apparently abrogated as 
multiple small inclusions were observed. The occurrence of multiple small inclusions (as 
opposed to one large inclusion) is indicative of a defective IncA protein [Fields et al., 2002; 
Hackstadt et al., 1999; Suchland et al., 2000]. The loss of functional IncA was attributed to a 
loss of translocation to the inclusion membrane as a result of the compound [Muschiol et al., 
2006]. These findings are significant because they demonstrate the existence of an INP0400-
sensitive protein or protein complex in Chlamydia likely to be a T3SS component. 
2.3 Inclusion proteins can be post-translationally modified by the Host 
The study of Chlamydia infection has largely focused on gross morphological changes during 
bacterial challenge. Re-organization of certain host markers and/or organelles implicates 
secreted bacterial effectors as being responsible for the observed phenotype. More recently, 
the role played by the inclusion in these phenomena has become more apparent. A complete 
identification of the inclusion proteome has still not been achieved. This could be due to the 
fact that (1) the proteome is likely to be dependent on the species of Chlamydia, the host cell 
or both; (2) it is dynamic and changes with length or phase of infection; (3) it is subject to the 
sensitivity and limitations of the techniques used to study it. Nevertheless, we can learn 
some basic facts about Chlamydia-host interactions through the study of known inclusion 
proteins. IncA and IncG for example, are two relatively well-studied proteins, each with 
identified binding partners. Importantly, discoveries regarding these two proteins have 
provided a starting point for the study of other inclusion proteins. 
IncA was the first Chlamydia protein found on the inclusion membrane [Rockey et al., 1995]. 
Since then, IncA has been studied in relative depth. Microinjection experiments 
demonstrated that the soluble domain of IncA from C. psittaci is exposed to the host 
cytoplasm and that a host kinase is responsible for phosphorylating IncA [Rockey et al., 
1997]. The function of IncA phosphorylation is unclear. C. trachomatis IncA is not known to 
be phosphorylated and no kinase for C. psittaci IncA has been identified [Fields and 
Hackstadt, 2002]. Furthermore, C. trachomatis IncA-mediated inhibition of endosomal fusion 
(discussed in detail below) was not reported to depend on phosphorylation [Paumet et al., 
2009]. In contrast, C. caviae IncA was shown to be phosphorylated at serine 17, and this post 
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translational modification was required for the inhibition of C. caviae inclusion development 
in cell lines [Alzhanov et al., 2004]. These differences, though not mutually exclusive, 
highlight the biological diversity among Chlamydiae.  
IncG is another Inc protein phosphorylated by the host [Scidmore and Hackstadt, 2001]. A 
yeast two-hybrid screen using C. trachomatis IncG as a bait revealed that the phosphoserine-
binding protein 14-3-3 binds the C-terminal region of IncG. Green fluorescent protein 
(GFP)-tagged 14-3-3 localized to the inclusion membrane in infected HeLa cells thus 
confirming the physiological relevance of this interaction. Serine 166 was determined to be a 
phosphorylation site as a mutation of this residue to alanine changed the electrophoretic 
mobility of IncG, consistent with a change in phosphorylation state. The S166A mutation 
abolishes interaction between IncG and 14-3-3 in a yeast two-hybrid assay. As for IncA, the 
kinase responsible for phosphorylating IncG is unknown. That both yeast and human cells 
apparently phosphorylate the same residue on IncG strongly suggests that the kinase is 
conserved from yeast to humans. Of course, the data do not rule out the possibility of 
multiple kinases being able to modify IncG.  
Why Chlamydia would need to traffic 14-3-3 to the inclusion membrane is unknown. One 
possibility is that it helps form a multi-protein complex at the inclusion-cytoplasm interface. 
Another possibility is that IncG sequesters 14-3-3 to the inclusion and prevents it from 
functioning in its normal location in the cell. In any case, the finding that a Chlamydia protein 
is able to interact with 14-3-3 is significant because it implicates a connection between the 
inclusion and host cell cycle regulation. It should be pointed out that the interaction between 
14-3-3 and IncG appears specific to C. trachomatis as the antibodies used to probe IncG on 
the inclusion of C. trachomatis strains A, B, Ba, C, D, E, F, G, H, I, J, K, L1, L2, and L3 did not 
cross-react with that of other species (namely C. psittaci and C. pneumoniae) [Scidmore and 
Hackstadt, 2001].  
To date, phosphorylation is the only post-translational modification detected on Inc 
proteins. Additional modifications, such as glycosylation, would certainly be interesting, as 
it would extend the variability and functions of the bacterial effectors and possibly highlight 
new pathways manipulated by Chlamydiae. As molecular biology techniques become more 
sophisticated and comprehensive, we will be able to better probe these types of questions in 
the future. 
In addition to modifying the phagosome they inhabit with the insertion of bacterial proteins 
through the T3SS, Chlamydia also manipulate the host proteins and lipids in order to change 
the nature of this compartment. They accomplish these modifications by (1) hijacking 
vesicles from the Golgi apparatus, (2) fusing with the multivesicular bodies and (3) 
corrupting host lipid droplets (see Figure 1-Right, and the following sections for more 
details). 
3. Evidence for the fusion of Golgi vesicles with the inclusion membrane 
The Golgi apparatus is the site of intracellular sorting of cargo. A variety of proteins—
including members of the Rab and SNARE families—regulate trafficking between the Golgi 
and the different intracellular compartments or the plasma membrane [Conibear and 
Stevens, 1998]. The specific distribution of these proteins ensures a high degree of 
processivity and organization in cargo sorting [McNew et al., 2000; Paumet et al., 2005; 
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Paumet et al., 2004]. Perturbations of this network result in aberrant localization of cargo to 
incorrect compartments. One hallmark of Chlamydia infection is the disruption of vesicular 
trafficking and the redirection of exocytic vesicles to the inclusion [Hackstadt et al., 1995; 
Heinzen et al., 1996]. The delivery of lipidic cargo to the inclusion likely gives Chlamydia 
access to nutrients required for its intra-inclusion survival. In addition, this may give the 
inclusion a Golgi-like identity, helping it to escape the degradative pathway. However, 
there is experimental evidence showing that withholding lipids does not starve and/or kill 
the pathogen, but rather destabilizes the inclusion thus weakening the infection [Robertson 
et al., 2009]. 
3.1 Host-derived sphingomyelin is a key component of Chlamydia development 
Direct evidence for an interaction between the inclusion and Golgi vesicles first came in 1995 
when a derivative of the fluorescent Golgi marker {N-[7-(4-nitrobenzo-2-oxa-1,3-
diazole)]}aminocaproylsphingosine (C6-NBD-ceramide) was shown to localize to the inclusion 
in a brefeldin A-sensitive manner [Hackstadt et al., 1995]. Brefeldin A inhibits cis-to-trans 
Golgi trafficking. Interestingly, Brefeldin A abrogated the association of the C6-NBD-ceramide 
with the inclusion leading to the conclusion that Chlamydiae intercept exocytic vesicles 
coming from the trans-Golgi network as opposed to the cis-Golgi face. The lipid species in 
question was determined to be sphingomyelin based on thin layer chromatographic analysis 
of purified inclusions. Later, Beatty and colleagues discovered that chemical inhibition of 
sphingomyelin acquisition in infected cells led to a corresponding loss of inclusion membrane 
integrity characterized by the absence of homotypic (inclusion-inclusion) fusion. In addition, 
they observed the premature differentiation from RBs to EBs, their early release, and a 
decrease in the ability of the bacteria to reactivate after reaching a persistent infection 
[Robertson et al., 2009]. Next, the authors inhibited host sphingomyelin synthesis at different 
steps during the metabolic pathway and analyzed the effects these compounds had on 
Chlamydia development. They found that pharmacologic inhibition by myriocin, which inhibits 
serine palmitoyltransferase (SPT) [Johnson et al., 2004], or fumonisin B1, which inhibits 
sphingosine N-acyltransferase downstreatm of SPT [Schroeder et al., 1994], correlated with the 
presence of multiple small inclusions in the cells tested [Robertson et al., 2009]. Addition of 
either dihydroceramide or sphingosine (two metabolites whose levels are negatively affected 
by myriocin) to the culture media restored normal inclusion morphology, validating that host 
sphingolipid synthesis is required for normal inclusion development. Chlamydia grown in cell 
lines with a nonfunctional SPT display defects similar to myriocin-treated cells. 
Complementation of the SPT proteins restores normal bacterial growth and development. 
Interestingly, subversion of Golgi-derived vesicles may actually occur through the hijacking of 
multivesicular bodies (MVBs) as treatment of infected cells with the MVB inhibitor U18666A 
disrupted the progression of the inclusion and produced phenotypes similar to that seen with 
myriocin treatment and SPT depletion [Robertson et al., 2009]. We discuss the manipulation of 
the MVBs by Chlamydia in section 4.  In summary, these data strongly support that host-
derived lipids, particularly sphingomyelin, are essential for Chlamydia. Interferring with  this 
process results in apparently dysfunctional inclusion membranes.  
3.2 Acquisition of Golgi-associated Rab proteins by the inclusion 
Rab proteins are members of a large family of proteins (Ras-like proteins) conserved across 
eukaryotes. They regulate many aspects of membrane trafficking from specificity and 
tethering to fusion [Hutagalung and Novick, 2011]. Rabs are found in either a soluble or 
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membrane bound form (Figure 3). They are attached to membranes via lipid anchors. In 
addition, they can be found in an “inactive” (GDP1-bound) or “active” (GTP2-bound) state. 
The activation state of Rabs is controlled by GEPs (guanine nucleotide exchange proteins) 
and GAPs (GTPase activating proteins). GEPs exchange GDP for GTP thus setting Rabs to 
an “active” state, whereas GAPs cause Rabs to hydrolyze the bound GTP to GDP causing 
them to enter an “inactive” state [Pfeffer, 2001; Segev, 2001]. 
During Chlamydia infection, Rabs involved in Golgi membrane fusion are found on the 
inclusion. Scidmore and colleagues analyzed the subcellular localization of eight Rabs 
(Rab1, 4, 5, 6, 7, 9, 10, 11) in cells infected with Chlamydia and found that the recruitment of 
specific Rabs to the inclusion was dependent on the species of Chlamydia [Rzomp et al., 
2003]. During C. trachomatis infection, overexpressed Rabs1, 4, 6 and 11 relocate to the 
inclusion membrane as visualized by fluorescent microscopy [Rzomp et al. 2003]. The 
association between Rab6 and the inclusion appears specific to C. trachomatis since Rab6 was 
not found on the inclusion when cells were infected with either C. muridarum or C. 
pneumoniae. Rab10 however, seemed to localize only to the inclusions of C. muridarum and C. 
pneumoniae but not to that of C. trachomatis. Interestingly, the presence of Rabs on the 
inclusion was not dependent on intact microtubules, as inhibition of microtubules by 
nocodazole did not affect Rab acquisition. 
 
Fig. 3. Rab Proteins Regulate Membrane Fusion Through GTP Hydrolysis. (Left) Rabs are 
inactive when bound to GDP. A network of regulatory proteins coordinates activation or 
inhibition of Rab activity. GTP Exchange Proteins (GEPs) replace bound GDP with GTP and 
activate the Rab protein (Right). GDP Dissociation Inhibitors (GDIs) keep the Rab bound to 
GDP and locked in the inactive state. Once activated, Rab GTPases recruit effector proteins 
that act on downstream targets to promote membrane tethering and fusion. Afterwards, a 
GTPase Activating Protein (GAP) stimulates the GTPase activity of the Rab GTPase, which 
in turn hydrolyzes bound GTP to GDP and enters an inactive state.  
                                                 
1 GDP: Guanosine diphosphate 
2 GTP: Guanosine triphosphate 
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Of the proteins found to associate with the inclusion, Rabs1, 6, and 10 are intimately 
involved in Golgi trafficking. Another Golgi Rab protein, Rab14, was later shown to localize 
to the C. trachomatis inclusion [Capmany and Damiani, 2010]. This localization was 
dependent on prenylation of Rab14 and occurred approximately 10-18 hours post-infection. 
Blocking bacterial protein synthesis with chloramphenicol treatment ablated the association 
between the inclusion and Rab14 suggesting that inclusion proteins are involved in Rab14 
acquisition. IncA is detectable approximately 10-12 hours post infection and does not seem 
to be the main effector for Rab14 acquisition because incubation of infected cells at 32C, 
which is known to block IncA expression on the inclusion surface [Fields et al., 2002], did 
not adversely affect the detection of Rab14 on the inclusion [Capmany and Damiani, 2010]. 
Notably, expression of the dominant negative (soluble) form of Rab14 inhibited Chlamydia 
growth most likely by blocking transport of sphingolipids to the inclusion.  
The recruitment of Rab proteins likely acts to facilitate selective fusion between the inclusion 
and other intracellular compartments. One possible mechanism is the formation of tethering 
complexes that tie the inclusion to another vesicle or organelle. Rabs have been shown to be 
present in tethering complexes mediated by the formation of scaffolding complexes or by 
the action of coiled-coils [Hutagalung & Novick 2011]. It is interesting to note that several 
inclusion proteins are predicted to form coiled-coils. However, their structures are yet to be 
defined.  
3.3 SNARE proteins are recruited to the inclusion membrane 
The proteins located on the surface of the inclusion membrane, including both bacterial 
effectors and host proteins, are unique because of their position at the interface between the 
host and the pathogen. The abnormal composition of the Chlamydia inclusion membrane is 
key to survival and a necessity for pathogenesis. In this section, we will look at the 
recruitment of specific host SNARE proteins to the inclusion.  
SNAREs are ubiquitously expressed proteins that mediate intracellular membrane fusion 
and are conserved from yeast to humans [Bock et al., 2001; Pelham, 1999]. They constitute 
the core machinery necessary to mediate specific membrane fusion [McNew et al., 2000; 
Parlati et al., 2002; Paumet et al., 2001]. As such, they are key regulators of all intracellular 
vesicle trafficking events and cargo transport steps. These proteins, present on the surface of 
almost all intracellular compartments [Chen and Scheller, 2001], assemble into a stable 
complex. As a result, both membranes are brought in a close apposition until fusion occurs 
(Figure 4). SNAREs are divided into two broad categories depending on their relative 
locations: target- (t-SNAREs) and vesicle- (v-SNAREs) SNAREs. Whereas the v-SNARE is 
always a single protein, the t-SNARE is composed of three subunits, one heavy chain and 
two light chains [Fukuda et al., 2000]. Notice that both light chains can be encoded in one or 
two separate proteins. A typical SNARE protein encodes a coiled-coil SNARE domain 
containing a heptad repeat motif spanning approximately 70 amino acids, and a C-terminal 
site that anchors it to a membrane. The SNARE domain contains a polar or charged residue 
located in the middle of the domain (also known as “zero-layer” [Fasshauer et al., 1998]) (see 
Figure 5A). The C-terminal anchoring site can be a simple hydrophobic transmembrane 
domain or a palmitoylation site.  
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Fusion specificity is largely encoded in the partnering of cognate SNARE proteins [McNew 
et al., 2000; Parlati et al., 2002; Paumet et al., 2001; Paumet et al., 2004]. Altogether, their 
characteristics designate SNAREs as excellent markers to determine the identity and activity 
of individual compartments in intracellular transport. Therefore, manipulation of individual 
SNARE proteins or of the complex itself may help intracellular pathogens to subvert normal 
trafficking patterns. As such, the recruitment of host SNAREs would afford the pathogen 
the ability to manipulate vesicular trafficking during infection.  
 
Fig. 4. Diagram of SNARE-Mediated Fusion. (A) In resting cells, SNARE proteins interact 
with effector proteins that control their availability. (B) Following a stimulatory signal, the t-
SNARE proteins interact to form a complex that in turn binds the v-SNARE. As a result, a 
trans-SNARE complex forms (four-helix bundle) between t-SNAREs on the target membrane 
and a v-SNARE on the vesicle. (C) As the SNARE complex zippers from N- to C-terminal, 
the space between the opposing membranes decreases. (D) Fusion occurs when both 
bilayers merge and form a fusion pore. Following fusion, the trans-SNARE complex 
becomes a cis-SNARE complex (so called because all the SNAREs are now located on the 
same membrane). (E) The cis-SNARE complex is disassembled by NSF, an ATPase bound to 
its co-factor -SNAP at the level of the SNARE motifs. (F) ATP hydrolysis dissociates the 
four-helix bundle, and the SNARE proteins are trafficked back to their original cellular 
compartments. 
Syntaxin 6 is a SNARE protein that localizes to the trans-Golgi network (TGN) and likely 
plays a role in mediating the fusion of Golgi-derived vesicles with endosomes and/or 
lysosomes [Bock et al., 1997]. Recently, Hackstadt and co-workers showed that Syntaxin 6 
relocates to the inclusion in a 18 hours post-infection [Moore et al., 2011]. Neither Syntaxin 4 
nor Syntaxin 16 were found to localize to the inclusion suggesting that the recruitment of 
Syntaxin 6 was specific. Furthermore, the re-location of Syntaxin 6 to the inclusion is 
conserved among several species including C. trachomatis, C. muridarum, C. caviae, and C. 
pneumoniae. Treatment of the infected host cells with chloramphenicol to inhibit bacterial 
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protein synthesis abrogated trafficking of Syntaxin 6 to the inclusion suggesting that 
bacterial effectors are necessary to induce this recruitment. The depletion of Syntaxin 6 by 
siRNA did not significantly affect the development of the inclusion nor change the 
recruitment of sphingomyelin to the inclusion [Moore et al., 2011]. Therefore, the role f 
Syntaxin6 during Chlamydia infection remains unclear. 
SNARE domains mediate protein-protein interactions between SNAREs and are required 
for fusion. Interestingly, the SNARE domain of Syntaxin 6 was not required for the 
recruitment to the inclusion. Instead, a small 10-amino acid “plasma membrane retrieval 
sequence” (TDRYGRLDRE) located N-terminal to the SNARE domain was found to be 
necessary for re-localization [Moore et al., 2011]. Deletion of this domain results in Syntaxin 
6 being present in the cytosol in non-infected cells [Watson and Pessin, 2000].  
3.4 Perspectives on Golgi fusion 
These observations bring up an important, and as yet unanswered, question: how do 
Chlamydia inclusions interact with exocytic vesicles to acquire sphingomyelin and 
presumably other lipids? The process apparently involves an energy-dependent step. 
Depletion of adenosine triphosphate (ATP) using 2-deoxyglucose and sodium azide 
significantly lessened the amount of fluorescent C6-NBD-ceramide found on the inclusion 
[Hackstadt et al., 1996]. Incubation of cells at 20C, which would presumably stop active 
vesicle fusion, also resulted in fewer C6-NBD-ceramide molecules observed on the inclusion 
membrane. These data lead to the attractive hypothesis that members of the eukaryotic 
membrane fusion machinery (i.e. SNAREs, Rabs) are involved in lipid acquisition. This 
possibility is supported by the fact that Syntaxin 6, a TGN SNARE is specifically recruited 
on the inclusion and could potentially be involved in the hijacking of the Golgi vesicles. The 
extent to which SNAREs play a role in Chlamydia pathogenesis is unclear, but evidence is 
mounting that the interaction between effectors and SNAREs (or the inhibition of certain 
SNAREs by the bacteria) is an important hallmark of infection.  
4. Multivesicular body markers are recruited to the Chlamydia inclusion  
Multivesicular bodies (MVBs) are endosomal compartments that are involved in the sorting 
of surface proteins to lysosomes. They get their name from the multiple intralumenal 
vesicles that form as the result of invagination events at the MVB membrane. Proteins 
destined for destruction by lysosomal degradation are mono-ubiquitinated within the MVB 
and cluster at the invagination sites so that they can be exposed to degradative proteins of 
the lysosome for destruction.  
It was traditionally thought that the Chlamydia inclusion did not intersect with the 
endosomal pathway. However, it appears that inclusions interact with MVBs and recruit 
MVB-associated proteins to their surface. In a series of microscopy studies, Beatty and 
colleagues identified three MVB markers—CD63, lysobisphosphatidic acid, and metastatic 
lymph node 64 (MLN64)—that trafficked to the inclusion after initial infection [Beatty, 2006]. 
Also observed was the absence of LAMP-1 (lysosome-associated membrane protein 1). This 
is in agreement with previous observations concerning the selective recruitment of vesicle-
associated membrane proteins (see Introduction). CD63 actually appeared to be both on the 
inclusion membrane and inside the inclusion. Cryo-electron microscopy confirmed this 
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finding [Beatty, 2006]. Lumenal CD63 seemed closely associated with the bacterial cell wall. 
Despite its close proximity with the bacteria, CD63 does not appear to play a significant role 
in the life cycle of C. trachomatis since the ablation of CD63 by small interfering RNA 
(siRNA) does not affect normal Chalmydia growth [Beatty, 2008]. 
The role of MVBs in Chlamydia infection is incompletely understood. One possibility is the 
acquisition of host lipids such as sphingomyelin [Beatty, 2008; Robertson et al., 2009]. The 
discovery that CD63 is transported in the inclusion lumen is important because it hints at a 
mechanism for acquisition of MVB components. At this point it is pure speculation as to 
what is being imported or how it is getting there. The most basic explanation for this 
phenomenon is that MVBs are fusing with the inclusion membrane and the internal vesicles 
are released into the lumen. Indeed, CD63 has been found on the internal vesicles of MVBs 
(microvesicles) [Heijnen et al., 1999]. This raises the interesting possibility that the internal 
vesicles of MVBs may actually be the main targets of Chlamydia as a source of nutrients.  
MVBs are not the only way that Chlamydia acquire new lipids. Recently, it has been 
demonstrated that these bacteria were also able to hijack and fuse lipid droplets with their 
inclusions.  
5. Corruption of host lipid droplets by Chlamydia 
5.1 Lipid droplets play a role in intracellular homeostasis 
Lipid droplets (LD) are intracellular stores of neutral lipids. LDs are found in a wide variety 
of eukaryotic cell types and are composed of both lipids and proteins. Once thought of as 
passive artifacts, LDs are now recognized as legitimate bioactive organelles. Disruption of 
lipid droplets (LDs) is associated with diseases such as type 2 diabetes and obesity [Farese 
and Walther, 2009]. It is believed that the initiation of LD formation begins with a swelling 
of the endoplasmic reticulum phospholipid bilayer caused by a gathering of neutral lipids. 
This is followed by a pinching off of the cytosol-facing leaflet to generate a cluster of neutral 
lipids, sterols, and sterol esters encased in a phospholipid monolayer. LDs are unique in the 
sense that they are the only recognized organelles to utilize a phospholipid monolayer. The 
exact function of LDs is unclear. Nevertheless, multiple interactions between LDs and other 
organelles suggest a physiologically significant role in cellular processes like metabolism.  
5.2 Chlamydia proteins interact with host lipid droplets 
A yeast genetic screen of the Chlamydia ORFeome uncovered three bacterial proteins (called 
Lipid Droplet Associated proteins, or Lda) that co-localized with yeast lipid droplets as 
measured by immunofluorescence: CT156 (Lda1), CT163 (Lda2), and CT473 (Lda3) [Kumar 
et al., 2006]. These proteins were also shown to bind to LDs in mammalian cells. 
Interestingly, Lda1 and Lda3 can be stably expressed in HeLa cells, but Lda2 seems to 
require LD biogenesis to be stable and avoid degradation in vivo. EGFP:Lda (enhanced green 
fluorescent protein) fusion proteins localized to both LDs and the inclusions themselves 
[Kumar et al., 2006].  
Lda2 is unstable in the absence of lipid droplets. Incubation of C. trachomatis-infected cells 
with the compound triacsin C, which inhibits synthesis of cholesterol esters and 
triacylglycerides, resulted in the formation of smaller inclusions than those found in non-
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treated cells [Kumar et al., 2006]. It is not yet clear what role LD biogenesis and corruption 
plays in Chlamydia infection, but it appears to be a process critical for bacterial survival. 
Likewise, the exact association of Lda proteins with the membranes is unknown. Although 
none of the three proteins appear to contain the bi-lobed TMD structure commonly 
associated with inclusion proteins, it is possible that Ldas contain other as-yet-
uncharacterized TMDs. It is also possible that Ldas are soluble and associate with host or 
Chlamydia proteins already present on the respective surfaces. Another compelling 
possibility is that post-translational modifications could lead to the addition of a lipid 
moiety that anchors the protein to the membrane surface. This matter is further complicated 
by the fact that no signal sequence specific for LDs has been identified. 
Another interesting question is whether these Lda proteins are translocated through a Type 
3 Secretion System. Secretion systems are a very efficient means of transporting proteins 
across biological membranes and are found in most, if not all, pathogenic bacteria studied to 
date (see section 2.1 of this chapter for more information on the Chlamydia T3SS). An active 
secretion apparatus would seem the most logical method of translocation because two lipid 
bi-layers separate the bacteria from the host cytosol (Figure 2A). The Ldas would have to 
traffic through these bilayers in order to gain access to lipid droplets. However, no T3SS 
screen has identified Lda proteins as being substrates for secretion so it is possible that Ldas 
are shuttled through another secretion system or by a novel method of translocation.  
The lipid droplets themselves are translocated across the inclusion membrane into the 
lumen where they appear to physically associate with the reticulate bodies [Cocchiaro et al., 
2008]. The mechanism by which LDs fuse with the inclusion membrane is unclear. LDs 
appear as whole, intact organelles throughout the process of translocation, providing 
evidence that the neutral lipids observed to be inside the inclusion are not the results of 
individual lipid molecules being trafficked across the membrane but rather bulk import of 
the entire droplet [Cocchiaro et al., 2008; Kumar et al., 2006]. A major unresolved issue is 
how the reticulate bodies interact with the lipid droplet once inside the inclusion lumen. 
Lipid droplets are also capable of fusing with one another in a process that may resemble 
SNARE-mediated membrane fusion [Bostrom et al., 2007]. In this study, the authors found 
that SNAP23, Syntaxin 5, and VAMP4 associated with LD homogenate. In addition, NSF 
and -SNAP, two proteins regulating SNARE complex dissociation, were also found to be 
associated with LDs via Western blot. This suggests that LD homotypic fusion might be 
SNARE-mediated. This conclusion is strengthened by the observation that inhibition of 
expression of any one SNARE (SNAP23, Syntaxin 5, or VAMP4) using siRNA constructs, 
significantly inhibited the rate of fusion of LDs. 
6. The Chlamydia inclusion intersects with early and late endosomes but 
avoids fusion with the lysosome and acidification 
6.1 Chlamydia does not fuse with the lysosomal compartment 
Bacteria that are detected by host innate immune cells are endocytosed into phagocytic 
compartments that successively fuse with early and late endosomes resulting in the 
acidification of the phagosome and, ultimately, fusion with the lysosome where they are 
destroyed (Figure 1-Left). It has been observed that enzymes contained in the lysosome 
including acid phosphatase, arylsulfase, and -acetylglucosaminidase do not enter the 
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Chlamydia inclusion demonstrating a lack of fusion with this compartment [Todd and Storz, 
1975]. How Chlamydiae block this process is incompletely understood, although new data 
have been gathered showing that Chlamydia is able to use SNARE-like proteins to block 
lysosomal fusion [Paumet et al., 2009; Wesolowski and Paumet, 2010] (see section 8). It 
remains unclear at which step elementary (or reticulate) bodies deviate from the lysosomal 
pathway. The situation is further complicated by the fact that certain markers for early and 
late endosomes are found on inclusions [van Ooij et al., 1997]. Yet, the inclusion itself does 
not acidify [Schramm et al., 1996].  
6.2 The transferrin receptor and CI-M6PR associate with the inclusion at distinct 
stages of infection 
Chlamydiae have long been known to avoid lysosomal degradation (see Introduction). 
However, its association with other endocytic compartments has been observed. Engel and 
co-workers have examined the localization of early and late endocytic markers (transferrin 
receptor (TfR) and cation-independent mannose-6-phosphate receptor (CI-M6PR), 
respectively) with the inclusion as a function of time in HeLa cells infected with C. 
trachomatis [van Ooij et al., 1997]. What they observed was that, at approximately 4 hours 
after infection, antibodies against the TfR and CI-M6PR3 stained brightly around the 
inclusion indicating possible fusion between the inclusion and early and late endosomes. 
These associations remained for up to 20 hours post-infection. Interestingly, the staining 
patterns were different for both proteins at 4 and 20 hours post-infection. At the later time 
point, a more defined membrane staining of the inclusion was observed as opposed to an 
aggregation-like pattern seen at 4 hours. Further interaction between TfR-containing 
endosomes and inclusions was observed when looking at the rate of transferrin recycling in 
C. trachomatis-infected cells. Recently, the association of endocytic SNAREs including 
VAMP3, VAMP7 and VAMP8 has been identified [Delevoye et al., 2008], supporting the 
interaction between the Chlamydia inclusion and the endocytic pathway.  
Wyrick and co-workers used a pH-sensitive fluorophore attached to elementary bodies of C. 
trachomatis to measure the relative pH of compartments in which the bacteria reside. They 
discovered that despite intersecting with late endosomes, the inclusion does not reach a pH 
lower than 6 [Schramm et al., 1996]. Also, the pharmacologic inhibition of Na+/K+ ATPases, 
which oppose acidification of endosomes due to vacuolar ATPases, inhibits Chlamydia 
growth presumably due to acidification of the phagosome [Schramm et al., 1996]. Inhibition 
of v-ATPases had no effect on bacterial growth. This is in agreement with microscopy data 
showing that v-ATPases are not found on inclusion membranes and that the compounds 
chloroquine and ammonium chloride (which raise the endosomal pH) had no effect on 
Chlamydia growth [Heinzen et al., 1996]. In addition to v-ATPases, neither LAMP1 nor 
LAMP2 were found on the inclusion membrane in the study. 
                                                 
3 It is interesting to note that the results in Van Ooij et al. (1997) regarding CI-M6PR localization are in 
direct contrast to those in Heinzen et al. (1996) in that the latter found no evidence for co-localization 
with the inclusion even though the same antibody (monoclonal anti-bovine CI-M6PR 2G11), same cell 
line (HeLa229), and same bacterial strain (C. trachomatis LGV L2) were used. Van Ooij et al. point out 
this discrepancy and suggest that the difference in bacterial load (multiplicity of infection, or MOI) 
during immunostaining could be the reason for these conflicting results. 
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In summary, although Chlamydia inclusions do interact to some extent with the endocytic 
pathway, they actively exclude certain endosomal markers—particularly those 
corresponding to lysosomes. Enzymes associated with lysosomal compartments were also 
apparently excluded from the inclusion lumen suggesting selective inhibition of fusion.  
7. Chlamydia use SNARE-like proteins to block SNARE-mediated lysosomal 
fusion 
The lack of a genetically pliable system for Chlamydia is a major obstacle in the study of the 
pathogen. However, scientists are finding new and innovative ways to study bacterial 
proteins in vitro. Inclusion-bound bacterial proteins are poorly characterized in terms of 
structure and function. Much research has focused on determining which proteins traffic to 
the inclusion, but their respective roles in infection are unknown. Inc proteins share very 
little sequence homology to any known eukaryotic proteins. Even within the same species of 
Chlamydia, the sequence homology of these proteins is very low. Importantly, all known 
members of Chlamydiae possess proteins localizing to the inclusion suggesting a critical role 
in survival. Recently, we have made progress in understanding how these proteins interact 
with host proteins. In particular, the interaction between IncA and members of the host 
membrane fusion machinery—namely SNARE proteins—have been indentified. The 
mechanism(s) uncovered in these types of studies will shed new light on the process by 
which Inc proteins help to subvert vesicle trafficking and establish a replicative niche inside 
the host. 
7.1 The SNARE domain is a specialized coiled-coil domain 
The defining feature of SNARE proteins is the presence of one or more SNARE domains. 
SNARE domains are around 70 amino acids in length and consist of tandem heptad repeats 
of the form A-B-C-D-E-F-G where A and D are hydrophobic residues and B, C, E, F, and G 
are polar or charged [Antonin et al., 2002; Sutton et al., 1998] (Figure 5A). In the SNARE 
domain, the A and D residues are known as layers and form tight hydrophobic interactions. 
Within the SNARE domain, there is a single polar or charged residue that resides in the D 
position towards the middle of the domain. This position is known as the 0-layer (zero-layer) 
and is discussed in detail below. In the vast majority of SNARE proteins, this residue is 
either a glutamine or an arginine4 [Fasshauer et al., 1998]. It has been proposed that the 
formation of the four-helix bundle begins at the N-terminus of the SNARE domain and 
proceeds straight through the C-terminal transmembrane domains [Melia et al., 2002; 
Pobbati et al., 2006]. This zipper-like motion pushes water molecules away from the 
hydrophobic core of the complex and brings the two membranes in close enough proximity 
to bring about fusion [Fasshauer, 2003; Melia et al., 2002; Stein et al., 2009]. This four-helix 
bundle assembles in a very organized and predictable way. The 0-layers of each SNARE 
domain align and interact in the final four-helix bundle as mentioned above. Likewise, each 
successive hydrophobic residue in the A and D positions will align with other hydrophobic 
residues on cognate SNAREs the same distance away from the 0-layer creating additional 
                                                 
4 The presence of either glutamine (Q) or arginine (R) in the central position is so conserved that SNARE 
proteins are often classified as Q- or R-SNAREs, respectively. This should not be confused with the t- 
and v-SNARE classification.  
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layers of hydrophobic interactions. Layers are numbered according to their distance from 
the 0-layer. In order to understand whether Chlamydia is using SNARE-like proteins to 
manipulate fusion, this characteristic SNARE domain was used as a matrix to identify 
similar domains in the Inc proteins [Delevoye et al., 2008]. 
 
Fig. 5. The SNARE Domain is Organized into Discrete Hydrophobic Layers. (A) The SNARE 
domain is a coiled-coil domain consisting of a central polar residue and multiple 
hydrophobic layers. This illlustration represents a typical SNARE domain. The hydrophobic 
residues are located in the A and D positions of the heptad repeats. The 0-layer is at position 
D, which is occupied by a polar or charged residue (usually glutamine or arginine). Layers 
are numbered according to their location relative to the 0-layer and are positive if counting 
towards the C-terminus and negative if counting towards the N-terminus. (B) Schematic of 
IncA, SNARE-like bacterial proteins found in C. trachomatis (CtrIncA) and C. caviae 
(CcaIncA). Residue numbers approximate the boundaries of each domain. The length of 
each domain is represented relative to length of the individual protein. Note that CcaIncA is 
actually 82 residues longer than CtrIncA. TMD=Transmembrane domain. 
7.2 IncA from C. trachomatis and C. caviae encodes SNARE-like motifs 
The severe loss of homeostatic regulation of vesicular trafficking in Chlamydia-infected cells 
and the aberrant (and Chlamydia-specific) translocation of proteins to the inclusion 
membrane suggest that bacterial effectors actively mediate this process. Two inclusion 
proteins of C. trachomatis and one protein from C. caviae show surprising structural 
homology to eukaryotic SNARE proteins. C. trachomatis IncA (herafter referred to as 
CtrIncA) is a ~34kDa protein composed of 273 amino acids. It contains the characteristic N-
terminal bi-lobed transmembrane domain (TMD) altogether spanning approximately 48 
amino acids (Figure 5B and Figure 2). Computational analysis determined that the TMD 
likely contains alpha helices [Dehoux et al., 2011]. It is unclear whether this hydrophobic 
stretch constitutes one long TMD or two shorter transmembrane domains separated by a 
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cytosol-exposed linker region. In either case, the regions flanking the TMD are exposed to 
the cytoplasm. It is currently unknown what, if any, role the N-terminal cytosolic domain 
plays in pathogenesis since no conserved functional domains have been identified in this 
region. On the other hand, the C-terminal cytosolic region is significantly longer and 
contains two SNARE-like domains shown to be involved in corruption of host vesicle 
trafficking [Delevoye et al., 2004; Delevoye et al., 2008; Paumet et al., 2009]. It is interesting 
to note that the distance between the two SNARE-like domains of CtrIncA (59 amino acids) 
closely approximates the distance between the two SNARE domains of SNAP-25 (62 amino 
acids)—a SNARE protein containing two light chains and involved in neuronal regulated 
exocytosis. This suggests that the two SNARE-like domains may be able to physically 
interact with each other in a parallel coiled-coil fashion as is the case with SNAP-25 [Sutton 
et al., 1998]. To date, no post-translational modifications have been associated with CtrIncA.  
Chlamydophila caviae IncA (hereafter referred to as CcaIncA) shares many of the same 
biochemical properties as CtrIncA including the presence of an N-terminal bi-lobed TMD, a 
cytoplasmic N-terminal domain, and two C-terminal SNARE-like domains separated by 48 
amino acids [Delevoye et al., 2004] (Figure 5B). CcaIncA is slightly larger than CtrIncA at 
355 amino acids and has an expected molecular weight of about 39kDa. As discussed above, 
CcaIncA is post-translationally modified by phosphorylation of serine 17 by an as-yet-
unidentified kinase [Alzhanov et al., 2004]. There is evidence that both CtrIncA and CcaIncA 
are able to form homodimers and homotetramers in vivo [Delevoye et al., 2004]. It is 
currently hypothesized that the coiled-coil/SNARE-like domains regulate multimerization, 
but the nature of this interaction and its significance is poorly understood. 
The hypothesis that IncA plays a role in regulating membrane fusion was first proposed 
when it was noticed that strains of C. trachomatis harboring mutations in their IncA gene 
developed inclusions that were smaller and more numerous than those of their wildtype 
counterparts [Suchland et al., 2000]. Whereas an infection with a wildtype strain results in 
an average of one large inclusion per infected cell, infection with an IncA-deficient strain 
results in the formation of multiple smaller inclusions that seemingly cannot fuse with one 
another. This homotypic fusion event seems to be important for pathogenesis because 
infection with strains of C. trachomatis that form non-fusogenic inclusions typically results in 
the manifestation of sub-clinical symptoms associated with Chlamydia [Geisler et al., 2001]. 
Supporting these observations, the microinjection of anti-IncA antibodies into the cytosol of 
infected cells replicated the non-fusogenic phenotype [Hackstadt et al., 1999] This is in 
agreement with a role of IncA in mediating homotypic fusion. In a yeast two-hybrid assay, 
CtrIncA, but not IncA from Chlamydophila psittaci, interacted with itself [Hackstadt et al., 
1999]. This is important because C. psittaci infections naturally produce non-fusogenic 
inclusions despite having an apparently intact IncA gene. It is possible that C. psittaci IncA 
lacks a functional homodimerization domain.  
The discovery that both CtrIncA and CcaIncA possess coiled-coil/SNARE-like domains 
prompted a detailed investigation of the interactions between IncA and SNARE proteins. 
When overexpressed in HeLa cells, CtrIncA binds to the v-SNAREs VAMP3, VAMP7, and 
VAMP8. This binding was confirmed in vitro for VAMP3 and VAMP8 [Delevoye et al., 
2008]. The interaction between IncA and VAMP7 is dependent on the presence of the 
SNARE motif of VAMP7, since the deletion of this domain ablated inter-protein binding. If 
glutamine Q244 of CtrIncA is mutated to an arginine, the in vivo interaction with the host 
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SNAREs is lost. VAMP3, VAMP7, and VAMP8 are v-SNAREs that contain an arginine at 
their zero-layer. These observations led to the speculation that the glutamine residue of IncA 
coordinates with the arginines of the VAMPs to facilitate binding as was observed in typical 
SNARE complex formation [Delevoye et al., 2008]. It remains to be seen if this property of 
binding to SNAREs is conserved across Chlamydiae.  
Another C. trachomatis protein, CT813, was found to have at least one putative coiled-coil 
domain in its C-terminal cytoplasmic region [Delevoye et al., 2008]. CT813 has only been 
shown to bind VAMP7 and, like IncA, this interaction was dependent on the presence of 
VAMP7 SNARE domain. No interaction between VAMP3, VAMP4, or VAMP8 was 
observed. CT813 has a putative length of 264 amino acids and a molecular weight of 
~29kDa. Similar to CtrIncA, it is predicted to encode a heptad repeat and contains a bi-lobed 
TMD. Whether CT813 has the capability to inhibit SNARE-mediated membrane fusion is not 
yet known.  
As more laboratories unravel the topology of the inclusion membrane, we can begin to learn 
more about the structure of the individual proteins themselves. Of the 59 putative C. 
trachomatis inclusion proteins analyzed computationally by Dehoux et al., 10 (16.9%) were 
noted to have significant coiled-coil potential. Likewise, about 20% of the putative inclusion 
proteins of C. pneumoniae are predicted to form coiled-coils [Dehoux et al., 2011]. 
Discovering binding partners for all of these proteins would greatly enhance our knowledge 
of Chlamydia infections and possibly reveal novel methods used by other intracellular 
bacteria to corrupt host resources for their own survival. 
7.3 The in vitro liposome fusion assay: A biochemical approach to a biological 
problem 
The inability to genetically manipulate Chlamydiae has proven to be a great challenge in the 
field. Scientists have developed novel techniques to circumvent this problem. One way to 
study Chlamydia proteins is by the directed mutagenesis of those proteins for use in in vitro 
assays. Our laboratory for example, has capitalized on a liposome fusion assay commonly 
used to study the biophysics of SNARE-mediated membrane fusion [Paumet et al., 2005; 
Varlamov et al., 2004; Weber et al., 1998].  
The in vitro liposome fusion assay is a robust system for studying SNARE complex 
formation and functionality in a cell-free environment. The assay allows for the reduction of 
the membrane fusion machinery to its core components so that the contributions of 
mutations, effectors, or bioactive compounds can be studied. Although variations of this 
assay exist, they all follow the same basic workflow. Full-length SNARE proteins are first 
purified using standard protein expression and purification techniques. Next, each SNARE 
is reconstituted into either a t- or v-SNARE liposome population depending on the protein 
in question. Both liposome populations are of the same composition, except that the v-
SNARE liposomes contain NBD and Rhodamine, a FRET (Fluorescence Resonance Energy 
Transfer) pair in which one fluorophore (Rhodamine) quenches the other (NBD) (Figure 
6A). After purifying and recovering the liposomes on a density gradient, both populations 
of liposomes are mixed at 37C. As the liposomes fuse, the distance between the FRET pair 
increases, and the quenching of NBD decreases. The rate of fusion is measured as an 
increase in NBD fluorescence (Figure 6B). The main advantage of this assay comes from the 
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fact that one can insert virtually any membrane-bound proteins into the liposome and study 
their effects on SNARE-mediated membrane fusion. Due to a lack of genetic tools for 
manipulating the Chlamydia inclusion, this technique may prove critical for our 
understanding of inclusion membrane dynamics and the function of IncA and other related 
bacterial effectors on membrane fusion. In fact, this assay has now been successfully used to 
study the function of bacterial effectors on SNARE-mediated membrane fusion [Paumet et 
al., 2009]. 
 
Fig. 6. Results of a Typical Liposome Fusion Assay Involving IncA. (A) t-SNARE and v-
SNARE liposome populations are incubated together at 37. To test the effect of IncA on 
SNARE-mediated membrane fusion, we created liposomes that contained IncA in addition 
to the v-SNARE. As a control, v-SNARE liposomes were created without IncA. Cognate 
SNARE interactions result in liposome fusion and dequenching of the FRET pair. (B) Percent 
of maximum fluorescence is plotted as a function of time. The t-SNARE liposomes contain 
Syntaxins 7 and 8 and Vti1b. v-SNARE liposomes contain either VAMP8 alone (-IncA) or 
VAMP8 plus IncA (+IncA). The presence of IncA on the v-SNARE liposome results in an 
inhibition of fusion as shown by a decrease in percent maximal fluorescence. 
7.4 CtrIncA and CcaIncA inhibit SNARE-mediated endocytic fusion 
The late endocytic/lysosomal SNARE complex is composed of the three t-SNAREs Syntaxin 
7, Syntaxin 8 and Vti1b, and the v-SNARE VAMP8 [Antonin et al., 2000; Mullock et al., 
2000]. During Chlamydia infection, VAMP8 has been shown to traffic to the inclusion 
membrane [Delevoye et al., 2008]. That IncA interacted with VAMP8 in vitro prompted us to 
investigate the role IncA played in altering endocytic membrane fusion. Using the in vitro 
liposome fusion assay described previously, our laboratory demonstrated that both CtrIncA 
and CcaIncA were capable of inhibiting endocytic fusion mediated by Syn7/Syn8/Vti1b (t-
SNARE) and its cognate v-SNARE, VAMP8 [Paumet et al., 2009] (Figure 6B). The location of 
IncA did not alter its ability to inhibit fusion since co-incubation of IncA with either the t- or 
v-SNARE resulted in an inhibition of fusion. This suggests that in vivo, IncA may be able to 
inhibit lysosomal fusion before VAMP8 is recruited to the inclusion. Using truncated 
mutants of IncA, our group determined that the N-terminal SNARE-like domain of either 
CtrIncA or CcaIncA is sufficient for inhibition. The role of the C-terminal SNARE-like 
domain remains to be determined. 
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To validate the inhibitory capacity of IncA in a cellular context, RBL-2H3 (rat basophilic 
leukemia) cells were transfected with myc-tagged CcaIncA containing a premature stop 
codon before the C-terminal SNARE-like domain [Paumet et al., 2009]. We used RBL-2H3 
cells because their secretory granules are lysosome-like and contain enzymes such as -
hexosaminidase. During stimulation with PMA (phorbol-12-myristate 13-
acetate)/Ionomycin, -hexosaminidase is released into the extracellular medium in a 
VAMP8-dependent manner [Paumet et al., 2000; Sander et al., 2008]. The amount of -
hexosaminidase present in the supernatant after stimulation can be used as a proxy for the 
capacity of the lysosomal granules to fuse with the plasma membrane. Myc-tagged CcaIncA 
co-localized with the secretory lysosomes in RBL cells. After stimulation, we observed a 
significant reduction in the level of -hexosaminidase in the supernatant. This illustrates 
that under physiological conditions, CcaIncA is able to inhibit the fusion of intracellular 
membranes. Figure 7 is a graphical representation of the proposed model for IncA-mediated 
membrane fusion inhibition [Wesolowski and Paumet, 2010]. 
 
Fig. 7. Proposed Model of IncA-Mediated Inhibition of Late Endocytic Fusion with the 
Inclusion. (Left) The fusion of endocytic compartments (EE and LE above) leads to the 
acidification of the phagosome and destruction of bacteria. This process is mediated by 
SNARE proteins, namely Syntaxin 7, Syntaxin 8, Vti1b and VAMP8. (Right) During 
Chlamydia infection, IncA is expressed on the surface of the inclusion where it interferes with 
the endocytic SNAREs and blocks membrane fusion with the lysosomes. As a result, 
Chlamydia inclusion avoids the degradative pathway.  
8. IncA and CT813 from C. trachomatis elicit antibody responses in humans 
There is currently no vaccine available for Chlamydia infections. The challenge has been to 
find a phylogenetically conserved Chlamydia protein capable of producing a potent and 
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prolonged immunological response. Finding the correct model organism in which to study 
this disease has also been a challenge. Mice are frequently used in immunology studies but 
are not the natural hosts of C. trachomatis, the causative agent of many human illnesses. 
Instead, mice are host to the related C. muridarum (also called Mouse Pneumonitis strain, or 
MoPn). While the use of an animal model has greatly facilitated the study of the 
pathogenesis of Chlamydiae infections [Brunham and Rey-Ladino, 2005], differences 
between the mouse and human etiologic agents of disease makes translation of results 
between both organisms inherently difficult to interpret. Nevertheless, progress is being 
made in the identification of immunogenic Chlamydia proteins in humans. 
Array-based technologies have been utilized to scan immunized human sera for reactivity 
with C. trachomatis proteins. For example, GST-tagged Chlamydia proteins have been coated 
on a microtiter plate to scan the sera of infected women [Wang et al., 2010]. Antibodies in 
the sera bound to their respective antigens were visualized by horseradish peroxidase-based 
ELISA. Of the 933 ORFs tested, 719 were antigenic (bound to human anti-Chlamydia 
antibodies). The antigens that were recognized by 50% or greater of the patients from whom 
the sera were taken were designated as “immunodominant antigens” [Wang et al., 2010]. 
The number of immunodominant antigens totaled 26. Included in those 26 antigens were 
IncA (also known as CT119 for C. trachomatis IncA) and CT813—two proteins with known 
SNARE protein-binding capacity. These proteins were recognized by 65% and 79% of the 
sera tested, respectively. Notably, 6 of the 26 identified antigens were previously shown by 
the same group to localize to the inclusion membrane [Li et al., 2008]. CT089, CT119 (IncA), 
CT147, CT442, CT529, and CT813 all elicited antibody responses from more than 65% of 
infected women and localize to the inclusion membrane.  
Antigens were further classified as being either infection-dependent or infection-
independent based on their reactivity with serum from mice and rabbits. Briefly, animals 
were either infected with live C. trachomatis serovar D or immunized with UV-killed bacteria 
and their sera collected after booster infections or immunizations [Wang et al., 2010]. The 
antigens recognized by immunized sera were designated “infection-independent” while the 
rest were “infection-dependent.”5 CT089, CT442, CT529, and CT813 were determined to be 
infection-dependent while immunized sera produced from inoculation with dead bacteria 
recognized IncA and CT147 [Wang et al., 2010].  
Interestingly, using a similar approach, Cruz-Fisher et al. found that antibodies against C. 
muridarum IncA (also known as TC0396) were only produced in mice infected with live 
elementary bodies not UV-killed organisms [Cruz-Fisher et al., 2011]. The antigenicity was 
not dependent on the route of infection as either intranasal or intravaginal inoculations 
resulted in the induction of a robust humoral response evidenced by the production of anti-
IncA (anti-TC0396) antibodies. The different requirements for production of antibody by 
live versus dead inoculations between the two Chlamydia species may reflect a difference in 
antigen processing and presentation between mice and humans. It could also be the result of 
differences between the pathology of C. muridarum and that of C. trachomatis.  
                                                 
5 Infection-dependent antigens were not antigenic in either mouse or rabbit but were antigenic in 
humans. The apparent absence of antigenicity in these animal experiments implies that antibody 
production is dependent on a live infection. 
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It is intriguing that some inclusion proteins appear to be highly immunogenic in humans, 
hinting at possible targets for future vaccine development6 [Li et al., 2007]. This observation 
makes studying the biochemical properties of inclusion proteins all the more important. 
Uncovering the physiologic role(s) of these bacterial effectors could greatly advance our ability 
to engineer immunogenic epitopes with minimal side effects for use in vaccine studies. 
Understanding more about the immunology of Chlamydia infections will lead to the design 
of novel vaccine strategies to combat the threat of sexually transmitted infections and the 
resulting medical complications. The discovery of highly antigenic bacterial effectors is a 
promising start. One challenge that remains is defining the immunogenic epitopes on each 
of these so-called “immunodominant antigens.” By narrowing down the sites of antibody 
binding, it may be possible to design synthetic peptides that protect against a broad range of 
C. trachomatis serovars and elicit long-lasting cellular immunity. 
9. Future research 
We are still far from providing a comprehensive picture of the molecular mechanisms of 
Chlamydia infection. High-throughput functional assays could reveal a wealth of information 
about Chlamydia’s ability to corrupt host signaling and trafficking pathways. However, the 
lack of a genetic system has been a barrier to the development of those assays that could 
potentially identify novel Chlamydia-specific antibiotic targets. One laboratory recently 
reported the generation of point mutations in C. trachomatis after treatment with ethyl 
methanesulfonate [Kari et al., 2011]. This group successfully isolated a clone mutated for the 
trpB tryptophan synthase gene, but otherwise isogenic to the wildtype parent strain. The 
isolation and identification of mutants, however, is labor-intensive and may not be 
amenable to large-scale genetic screens in most laboratories. However, this represents an 
important step in beginning to manipulate the Chlamydia genome. 
The function of inclusion membrane proteins needs to be explored more in depth. Their 
location at the host-pathogen interface makes them ideal candidates for virulence factors 
and also as druggable targets for novel therapeutics. Despite years of research on Chlamydia, 
little is known about the role of inclusion proteins in the etiology of infection. The best-
characterized inclusion protein is IncA. Although a role for IncA in promoting homotypic 
inclusion fusion has been known for over ten years [Hackstadt et al., 1999], only recently has 
the interaction between the host endocytic SNARE complex and IncA been explored in 
detail. That other Inc proteins also contain putative coiled-coil domains strongly suggests 
that they may interact with cytosol-exposed host proteins including SNAREs. These 
interactions between Chlamydia and host proteins could potentially explain many of the 
observations noted by others throughout the years such as the homotypic fusion of 
inclusions, inhibition of fusion with late endosomes/lysosomes, or the acquisition of Golgi-
associated membrane markers.  
                                                 
6 It may seem counterintuitive that bacterial proteins expressed only within live infected host cells could 
have therapeutic abilities since those antibodies would most likely not bind the extracellular EB form of 
the organism. Recent data using mice, however, show that a vaccine consisting of recombinant CtrIncA 
plus murine interleukin-12 administered prior to genital challenge by C. trachomatis confers resistance to 
the pathogen beyond background levels (Li et al. 2007). This vaccine resulted in a robust humoral 
response correlating with reduced sequelae associated with genital infection. 
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Despite the lack of a tractable genetic system for studying Chlamydia, new and important 
discoveries are still being made. In particular, the cell biology of Chlamydia infection has 
revealed how intracellular infection can alter host vesicle trafficking. The availability of 
compartment-specific markers and fluorescent probes has greatly accelerated our 
understanding of the re-localization of host proteins and lipids during infection. The study 
regarding sphingomyelin is one example of how the use of cell biology techniques has 
overcome the inherent problems that come with working with a genetically recalcitrant 
bacterium. In order to continue to study the molecular mechanisms of Chlamydia infection, 
new techniques will have to be developed.  
10. Conclusion 
Despite strong efforts to combat Chlamydia, it continues to be the most frequently reported 
bacterial STD in the United States. Although Chlamydia is commonly associated with 
venereal diseases, infection also occurs in the eyes or lungs. Infection of tissues surrounding 
the eye can result in a form of infectious blindness known as trachoma—a widespread 
problem in regions of Africa, South America, and Asia (data from World Health 
Organization, Global Health Observatory). Chlamydia pneumoniae can colonize lung tissue 
and is the causative agent of a form of bacteria-induced pneumonia. Recent studies have 
also attributed increased risk of heart disease—including atherosclerosis—to Chlamydia 
infection [Beagley et al., 2009].  
The normal course of treatment for Chlamydia infections involves the use of antibiotics. 
However, non-specific antibiotics like the ones used to treat Chlamydia may negatively affect 
the mucosal microbiome that helps to regulate essential processes like digestion, 
inflammation and immune responses. Additionally, some antibiotics have detrimental side 
effects. Therefore, finding novel and specific drug targets that protect against a wide range 
of Chlamydia serovars is of extreme importance.  
As an obligate intracellular pathogen, Chlamydiae must adapt to acquire host nutrients while 
avoiding destruction by innate immune cells. Through the selective interactions with Golgi-
derived vesicles, lipid droplets, and multivesicular bodies, Chlamydiae obtain host nutrients 
such as sphingomyelin that support growth and accelerate infection. While they promote 
fusion with these organelles, Chlamydiae simultaneously inhibit fusion with lysosomes and 
avoid compartment acidification and degradation by processes that are still unclear. 
Evidence suggests that Chlamydiae employ a Type 3 Secretion System to translocate a 
special subset of effectors known as Inc proteins to the inclusion membrane surface, and that 
these proteins are involved in subversion of host vesicle trafficking. The identity of these Inc 
proteins is still unclear. This is hampered by the genetic diversity of the bacteria themselves 
and a lack of genetic tools for studying Chlamydiae. Incs known to localize to the inclusion 
membrane share little amino acid sequence homology, but may share structural or 
functional similarities including the presence of a bi-lobed hydrophobic transmembrane 
domain and, for a number of putative Incs, coiled-coil domain(s). IncA is one such inclusion 
protein that is transported by a T3SS and resides on the inclusion membrane. CtrIncA has 
been shown to interact with host SNARE proteins VAMP3, VAMP7, and VAMP8 possibly 
via its coiled-coils. It also inhibits endocytic SNARE-mediated fusion in a specific manner. 
Another C. trachomatis protein, CT813, localizes to the inclusion membrane [Chen et al., 
2006] and may also interfere with SNARE-mediated membrane fusion [Delevoye et al., 
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2008]. The biophysical studies of IncA presented in this chapter begin to reconcile our 
understanding of host vesicle subversion with what we know about inclusion membrane 
composition and could lead to the future design of novel anti-Chlamydia therapeutics. 
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